CJC-1295 DAC 5mg

Your Trusted Source for Dragon Pharma CJC-1295 DAC Peptide

Dragon Pharma CJC-1295 DAC 2mg is a long-acting growth hormone–releasing hormone (GHRH) analog frequently used in scientific research to investigate hormone regulation, pituitary signaling, and extended-release peptide pharmacokinetics.

Product Overview

Dragon Pharma CJC-1295 DAC is a synthetic GHRH analog engineered with a Drug Affinity Complex (DAC) to significantly extend its half-life in vivo. This modification enables prolonged interaction with GHRH receptors (GHRH-R), making CJC-1295 DAC a valuable tool for endocrine, metabolic, and peptide-signaling research. Laboratory studies frequently use CJC-1295 DAC to explore continuous GH release, pharmacodynamics of long-acting peptides, and comparative modeling with shorter analogs such as CJC-1295 (no DAC) or Sermorelin.

Mechanism of Action

CJC-1295 DAC functions by activating the GHRH receptor in the pituitary, stimulating downstream GH release through cyclic AMP signaling pathways. The addition of the Drug Affinity Complex enables binding to circulating albumin, substantially increasing peptide stability and duration of action. This makes Dragon Pharma CJC-1295 DAC a preferred compound in studies investigating sustained GH pulsatility, endocrine feedback modulation, and long-term peptide pharmacology.

Key CJC-1295 DAC Research Applications

• Studied for its prolonged activation of GHRH receptors and extended GH secretion patterns
• Used in endocrine research exploring long-acting peptide pharmacokinetics
• Valuable in studies comparing short-acting vs. long-acting GHRH analogs
• Frequently used to evaluate GH/IGF-1 axis modulation in controlled experimental models
• Combined in research with GHS peptides such as Ipamorelin or GHRP-2 to observe synergistic GH responses

Usage & Handling

Reconstitution commonly involves bacteriostatic water to achieve desired study concentrations.

Form: Lyophilized powder for maximum stability.
Conditions:
Short-term: Refrigerate at 2–8°C.
Long-term: Store at -80°C for extended preservation.
Handling: Avoid freeze-thaw cycles; aliquot for experimental use. Protect from light, air, and moisture.
Solution Stability: Use sterile buffers (pH 5–6); store at 4°C for up to 30 days or freeze for longer periods.

For research purposes only. Not for human use or therapeutic applications.

Lab-Tested for Quality and Purity

Dragon Pharma CJC-1295 DAC is verified using analytical techniques such as HPLC and mass spectrometry to confirm sequence identity, purity, structural integrity, and stability. Each batch is produced under strict research-grade specifications to ensure reproducibility across experiments.

Dosage, Administration & Synergistic Research Peptides

Experimental dosing models typically reference concentrations in the range of 200–500 mcg per administration depending on study design and duration. Due to its long half-life, CJC-1295 DAC is often applied in less frequent dosing intervals compared to non-DAC GHRH analogs.

In laboratory models, researchers frequently pair CJC-1295 DAC with GHS peptides such as Ipamorelin or GHRP-6 to assess combined effects on GH pulsatility and receptor pathway synergy.

Post-Cycle Considerations

No post-cycle therapy (PCT) is utilized in laboratory research as CJC-1295 DAC does not interact with androgenic pathways. Study sequences may be terminated or modified without rebound suppression effects.

FAQ

What is CJC-1295 DAC?

CJC-1295 DAC is a long-acting GHRH analog used in research investigating pituitary signaling, GH release, and peptide pharmacokinetics. It is not intended for human use.

What makes CJC-1295 DAC different from CJC-1295 (no DAC)?

The DAC modification allows CJC-1295 to bind to albumin, significantly extending its half-life. Researchers use DAC versions for long-duration models and no-DAC versions for pulsatile GH studies.

Can CJC-1295 DAC be combined with Ipamorelin?

Yes, in research settings, CJC-1295 DAC is frequently studied with Ipamorelin to evaluate combined GH stimulation through separate GHRH and GHS pathways.

How much CJC-1295 DAC is used in studies?

Literature-based research models typically reference 200–500 mcg per administration at extended intervals due to the peptide's long activity. These values are not intended as usage guidance.

Where to buy CJC-1295 DAC?

CJC-1295 DAC is available for research purchase through BuyDragonPharma.com, the official distributor of Dragon Pharma peptides.

External References

• CJC-1295 DAC on PubChem
• CJC-1295 studies on PubMed
• CJC-1295 overview on Wikipedia
• CJC-1295 no-DAC & Ipamorelin Blend